InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Bohen Sean, Chief Executive Officer. Insider active across 1 companies, notably Olema Pharmaceuticals, Inc.. Cumulatively, 8 filings have been recorded. The latest transaction was disclosed on 14 October 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations8 total
€20,8085,000 shares@ €4.16170.0018% mcap68.2% of flow
Common Stock
SEC:0001415889-21-004885·
€20,8085,000 shares@ €4.16170.0018% mcap34.1% of flow
Common Stock
SEC:0001415889-21-004885:0·
€4,4751,085 shares@ €4.12420.0004% mcap14.7% of flow
Common Stock
SEC:0001415889-21-004613·
€4,4751,085 shares@ €4.12420.0004% mcap7.3% of flow
Common Stock
SEC:0001415889-21-004613:0·
€1,682413 shares@ €4.07310.0001% mcap5.5% of flow
Common Stock
SEC:0001415889-21-004306·
€1,682413 shares@ €4.07310.0001% mcap2.8% of flow
Common Stock
SEC:0001415889-21-004306:0·
€3,548871 shares@ €4.0740.0003% mcap11.6% of flow
Common Stock
SEC:0001415889-21-004247·
€3,548871 shares@ €4.0740.0003% mcap5.8% of flow
Common Stock
SEC:0001415889-21-004247:0·
8 of 8 declarations
About Bohen Sean
Sean Bohen is the Chief Executive Officer at Olema Pharmaceuticals, Inc. He is responsible for the strategic direction of the company and the execution of its business objectives. With a strong background in the industry, he has demonstrated his ability to lead teams and drive growth initiatives. His leadership is crucial for the sustainable development and profitability of the company.
